nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitric Oxide—CYP3A4—Topotecan—ovarian cancer	0.0547	0.271	CbGbCtD
Nitric Oxide—CYP2B6—Doxorubicin—ovarian cancer	0.0475	0.235	CbGbCtD
Nitric Oxide—CYP3A4—Vinorelbine—ovarian cancer	0.0385	0.191	CbGbCtD
Nitric Oxide—GUCY1A2—myometrium—ovarian cancer	0.0327	0.0608	CbGeAlD
Nitric Oxide—CYP3A4—Paclitaxel—ovarian cancer	0.0271	0.134	CbGbCtD
Nitric Oxide—GUCY1A2—uterine cervix—ovarian cancer	0.0254	0.0473	CbGeAlD
Nitric Oxide—GUCY1A3—myometrium—ovarian cancer	0.0206	0.0383	CbGeAlD
Nitric Oxide—GUCY1B3—myometrium—ovarian cancer	0.0204	0.038	CbGeAlD
Nitric Oxide—CYP3A4—Docetaxel—ovarian cancer	0.0196	0.0969	CbGbCtD
Nitric Oxide—GUCY1A2—female reproductive system—ovarian cancer	0.019	0.0355	CbGeAlD
Nitric Oxide—ALDH2—myometrium—ovarian cancer	0.0173	0.0323	CbGeAlD
Nitric Oxide—GUCY1A3—uterine cervix—ovarian cancer	0.016	0.0298	CbGeAlD
Nitric Oxide—GUCY1B3—uterine cervix—ovarian cancer	0.0159	0.0296	CbGeAlD
Nitric Oxide—GUCY1A2—testis—ovarian cancer	0.0154	0.0286	CbGeAlD
Nitric Oxide—GUCY1A3—decidua—ovarian cancer	0.0153	0.0284	CbGeAlD
Nitric Oxide—GUCY1B3—decidua—ovarian cancer	0.0151	0.0282	CbGeAlD
Nitric Oxide—CYP3A4—Doxorubicin—ovarian cancer	0.0146	0.0722	CbGbCtD
Nitric Oxide—GUCY1A3—endometrium—ovarian cancer	0.0145	0.027	CbGeAlD
Nitric Oxide—GUCY1B3—endometrium—ovarian cancer	0.0144	0.0268	CbGeAlD
Nitric Oxide—ALDH2—uterine cervix—ovarian cancer	0.0135	0.0251	CbGeAlD
Nitric Oxide—GUCY1A3—uterus—ovarian cancer	0.0133	0.0249	CbGeAlD
Nitric Oxide—GUCY1B3—uterus—ovarian cancer	0.0132	0.0247	CbGeAlD
Nitric Oxide—ALDH2—decidua—ovarian cancer	0.0129	0.0239	CbGeAlD
Nitric Oxide—ALDH2—endometrium—ovarian cancer	0.0122	0.0227	CbGeAlD
Nitric Oxide—GUCY1A3—female reproductive system—ovarian cancer	0.012	0.0223	CbGeAlD
Nitric Oxide—Dry throat—Paclitaxel—ovarian cancer	0.0119	0.0479	CcSEcCtD
Nitric Oxide—GUCY1B3—female reproductive system—ovarian cancer	0.0119	0.0222	CbGeAlD
Nitric Oxide—GUCY1A3—bone marrow—ovarian cancer	0.0113	0.0211	CbGeAlD
Nitric Oxide—ALDH2—gonad—ovarian cancer	0.0113	0.0211	CbGeAlD
Nitric Oxide—ALDH2—uterus—ovarian cancer	0.0112	0.0209	CbGeAlD
Nitric Oxide—GUCY1B3—bone marrow—ovarian cancer	0.0112	0.0209	CbGeAlD
Nitric Oxide—GUCY1A2—lymph node—ovarian cancer	0.0111	0.0208	CbGeAlD
Nitric Oxide—GUCY1A3—female gonad—ovarian cancer	0.0109	0.0203	CbGeAlD
Nitric Oxide—GUCY1A3—vagina—ovarian cancer	0.0108	0.0202	CbGeAlD
Nitric Oxide—GUCY1B3—female gonad—ovarian cancer	0.0108	0.0202	CbGeAlD
Nitric Oxide—GUCY1B3—vagina—ovarian cancer	0.0108	0.0201	CbGeAlD
Nitric Oxide—Convulsion—Altretamine—ovarian cancer	0.0102	0.0409	CcSEcCtD
Nitric Oxide—ALDH2—female reproductive system—ovarian cancer	0.0101	0.0188	CbGeAlD
Nitric Oxide—Pneumothorax—Paclitaxel—ovarian cancer	0.00984	0.0395	CcSEcCtD
Nitric Oxide—GUCY1A3—testis—ovarian cancer	0.00968	0.018	CbGeAlD
Nitric Oxide—GUCY1B3—testis—ovarian cancer	0.00961	0.0179	CbGeAlD
Nitric Oxide—ALDH2—bone marrow—ovarian cancer	0.00954	0.0178	CbGeAlD
Nitric Oxide—Thrombocytopenia—Altretamine—ovarian cancer	0.00939	0.0377	CcSEcCtD
Nitric Oxide—ALDH2—female gonad—ovarian cancer	0.0092	0.0171	CbGeAlD
Nitric Oxide—ALDH2—vagina—ovarian cancer	0.00914	0.017	CbGeAlD
Nitric Oxide—ALDH2—testis—ovarian cancer	0.00816	0.0152	CbGeAlD
Nitric Oxide—GUCY1A3—lymph node—ovarian cancer	0.00702	0.0131	CbGeAlD
Nitric Oxide—GUCY1B3—lymph node—ovarian cancer	0.00697	0.013	CbGeAlD
Nitric Oxide—Dizziness—Altretamine—ovarian cancer	0.00635	0.0255	CcSEcCtD
Nitric Oxide—ALDH2—lymph node—ovarian cancer	0.00591	0.011	CbGeAlD
Nitric Oxide—Pneumothorax—Epirubicin—ovarian cancer	0.00563	0.0226	CcSEcCtD
Nitric Oxide—Chest discomfort—Paclitaxel—ovarian cancer	0.00553	0.0222	CcSEcCtD
Nitric Oxide—Pneumothorax—Doxorubicin—ovarian cancer	0.00521	0.0209	CcSEcCtD
Nitric Oxide—CYP2B6—gonad—ovarian cancer	0.00508	0.00946	CbGeAlD
Nitric Oxide—Chest discomfort—Docetaxel—ovarian cancer	0.00469	0.0188	CcSEcCtD
Nitric Oxide—CYP2B6—female reproductive system—ovarian cancer	0.00454	0.00845	CbGeAlD
Nitric Oxide—Haemoglobin—Topotecan—ovarian cancer	0.00429	0.0173	CcSEcCtD
Nitric Oxide—Haemorrhage—Topotecan—ovarian cancer	0.00427	0.0172	CcSEcCtD
Nitric Oxide—Haemoglobin—Melphalan—ovarian cancer	0.00421	0.0169	CcSEcCtD
Nitric Oxide—Haemorrhage—Melphalan—ovarian cancer	0.00418	0.0168	CcSEcCtD
Nitric Oxide—CYP2B6—vagina—ovarian cancer	0.0041	0.00764	CbGeAlD
Nitric Oxide—Angiopathy—Topotecan—ovarian cancer	0.00388	0.0156	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Topotecan—ovarian cancer	0.00385	0.0155	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Melphalan—ovarian cancer	0.00377	0.0151	CcSEcCtD
Nitric Oxide—CYP2B6—testis—ovarian cancer	0.00366	0.00682	CbGeAlD
Nitric Oxide—Convulsion—Chlorambucil—ovarian cancer	0.00362	0.0145	CcSEcCtD
Nitric Oxide—CYP3A4—female reproductive system—ovarian cancer	0.00343	0.00638	CbGeAlD
Nitric Oxide—Cardiac disorder—Vinorelbine—ovarian cancer	0.00339	0.0136	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00334	0.0134	CcSEcCtD
Nitric Oxide—Angiopathy—Vinorelbine—ovarian cancer	0.00332	0.0133	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00329	0.0132	CcSEcCtD
Nitric Oxide—Chest pain—Topotecan—ovarian cancer	0.00317	0.0127	CcSEcCtD
Nitric Oxide—Convulsion—Melphalan—ovarian cancer	0.00316	0.0127	CcSEcCtD
Nitric Oxide—Chest pain—Melphalan—ovarian cancer	0.0031	0.0125	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.00301	0.0121	CcSEcCtD
Nitric Oxide—Nervous system disorder—Topotecan—ovarian cancer	0.00298	0.012	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Topotecan—ovarian cancer	0.00297	0.0119	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Melphalan—ovarian cancer	0.00291	0.0117	CcSEcCtD
Nitric Oxide—Hypotension—Melphalan—ovarian cancer	0.00278	0.0112	CcSEcCtD
Nitric Oxide—Chest pain—Vinorelbine—ovarian cancer	0.00271	0.0109	CcSEcCtD
Nitric Oxide—Dyspnoea—Topotecan—ovarian cancer	0.00271	0.0109	CcSEcCtD
Nitric Oxide—Dyspnoea—Melphalan—ovarian cancer	0.00265	0.0106	CcSEcCtD
Nitric Oxide—Nervous system disorder—Vinorelbine—ovarian cancer	0.00255	0.0102	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00254	0.0102	CcSEcCtD
Nitric Oxide—Bradycardia—Paclitaxel—ovarian cancer	0.0025	0.0101	CcSEcCtD
Nitric Oxide—Haemoglobin—Paclitaxel—ovarian cancer	0.00247	0.00993	CcSEcCtD
Nitric Oxide—Haemorrhage—Paclitaxel—ovarian cancer	0.00246	0.00988	CcSEcCtD
Nitric Oxide—Hypotension—Vinorelbine—ovarian cancer	0.00243	0.00975	CcSEcCtD
Nitric Oxide—Dyspnoea—Vinorelbine—ovarian cancer	0.00232	0.0093	CcSEcCtD
Nitric Oxide—Cardiac disorder—Paclitaxel—ovarian cancer	0.00228	0.00917	CcSEcCtD
Nitric Oxide—Angiopathy—Paclitaxel—ovarian cancer	0.00223	0.00896	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00222	0.0089	CcSEcCtD
Nitric Oxide—Haemoglobin—Docetaxel—ovarian cancer	0.00209	0.00841	CcSEcCtD
Nitric Oxide—Haemorrhage—Docetaxel—ovarian cancer	0.00208	0.00837	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.00203	0.00816	CcSEcCtD
Nitric Oxide—Dizziness—Topotecan—ovarian cancer	0.00201	0.00806	CcSEcCtD
Nitric Oxide—Cardiac disorder—Docetaxel—ovarian cancer	0.00193	0.00777	CcSEcCtD
Nitric Oxide—Headache—Topotecan—ovarian cancer	0.0019	0.00764	CcSEcCtD
Nitric Oxide—Angiopathy—Docetaxel—ovarian cancer	0.00189	0.00759	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.00188	0.00755	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Docetaxel—ovarian cancer	0.00188	0.00754	CcSEcCtD
Nitric Oxide—Convulsion—Paclitaxel—ovarian cancer	0.00185	0.00745	CcSEcCtD
Nitric Oxide—Chest pain—Paclitaxel—ovarian cancer	0.00182	0.00732	CcSEcCtD
Nitric Oxide—Shock—Paclitaxel—ovarian cancer	0.00172	0.0069	CcSEcCtD
Nitric Oxide—Dizziness—Vinorelbine—ovarian cancer	0.00172	0.0069	CcSEcCtD
Nitric Oxide—Nervous system disorder—Paclitaxel—ovarian cancer	0.00171	0.00688	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00171	0.00687	CcSEcCtD
Nitric Oxide—Hypotension—Paclitaxel—ovarian cancer	0.00163	0.00656	CcSEcCtD
Nitric Oxide—Headache—Vinorelbine—ovarian cancer	0.00163	0.00654	CcSEcCtD
Nitric Oxide—Convulsion—Docetaxel—ovarian cancer	0.00157	0.00631	CcSEcCtD
Nitric Oxide—Dyspnoea—Paclitaxel—ovarian cancer	0.00156	0.00626	CcSEcCtD
Nitric Oxide—Chest pain—Docetaxel—ovarian cancer	0.00154	0.0062	CcSEcCtD
Nitric Oxide—Shock—Docetaxel—ovarian cancer	0.00146	0.00585	CcSEcCtD
Nitric Oxide—Nervous system disorder—Docetaxel—ovarian cancer	0.00145	0.00583	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Docetaxel—ovarian cancer	0.00145	0.00582	CcSEcCtD
Nitric Oxide—Bradycardia—Epirubicin—ovarian cancer	0.00143	0.00575	CcSEcCtD
Nitric Oxide—Haemoglobin—Epirubicin—ovarian cancer	0.00141	0.00567	CcSEcCtD
Nitric Oxide—Haemorrhage—Epirubicin—ovarian cancer	0.00141	0.00565	CcSEcCtD
Nitric Oxide—Hypotension—Docetaxel—ovarian cancer	0.00138	0.00556	CcSEcCtD
Nitric Oxide—Bradycardia—Doxorubicin—ovarian cancer	0.00132	0.00532	CcSEcCtD
Nitric Oxide—Dyspnoea—Docetaxel—ovarian cancer	0.00132	0.0053	CcSEcCtD
Nitric Oxide—Haemoglobin—Doxorubicin—ovarian cancer	0.00131	0.00525	CcSEcCtD
Nitric Oxide—Cardiac disorder—Epirubicin—ovarian cancer	0.0013	0.00524	CcSEcCtD
Nitric Oxide—Haemorrhage—Doxorubicin—ovarian cancer	0.0013	0.00522	CcSEcCtD
Nitric Oxide—Angiopathy—Epirubicin—ovarian cancer	0.00128	0.00512	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Epirubicin—ovarian cancer	0.00127	0.00509	CcSEcCtD
Nitric Oxide—Cardiac disorder—Doxorubicin—ovarian cancer	0.00121	0.00485	CcSEcCtD
Nitric Oxide—Angiopathy—Doxorubicin—ovarian cancer	0.00118	0.00474	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00117	0.00471	CcSEcCtD
Nitric Oxide—Dizziness—Paclitaxel—ovarian cancer	0.00116	0.00464	CcSEcCtD
Nitric Oxide—Headache—Paclitaxel—ovarian cancer	0.00109	0.0044	CcSEcCtD
Nitric Oxide—Convulsion—Epirubicin—ovarian cancer	0.00106	0.00426	CcSEcCtD
Nitric Oxide—Chest pain—Epirubicin—ovarian cancer	0.00104	0.00418	CcSEcCtD
Nitric Oxide—Shock—Epirubicin—ovarian cancer	0.000982	0.00395	CcSEcCtD
Nitric Oxide—Convulsion—Doxorubicin—ovarian cancer	0.000981	0.00394	CcSEcCtD
Nitric Oxide—Nervous system disorder—Epirubicin—ovarian cancer	0.000979	0.00393	CcSEcCtD
Nitric Oxide—Dizziness—Docetaxel—ovarian cancer	0.000979	0.00393	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Epirubicin—ovarian cancer	0.000978	0.00393	CcSEcCtD
Nitric Oxide—Chest pain—Doxorubicin—ovarian cancer	0.000964	0.00387	CcSEcCtD
Nitric Oxide—Hypotension—Epirubicin—ovarian cancer	0.000933	0.00375	CcSEcCtD
Nitric Oxide—Headache—Docetaxel—ovarian cancer	0.000928	0.00373	CcSEcCtD
Nitric Oxide—Shock—Doxorubicin—ovarian cancer	0.000909	0.00365	CcSEcCtD
Nitric Oxide—Nervous system disorder—Doxorubicin—ovarian cancer	0.000906	0.00364	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000905	0.00363	CcSEcCtD
Nitric Oxide—Dyspnoea—Epirubicin—ovarian cancer	0.00089	0.00358	CcSEcCtD
Nitric Oxide—Hypotension—Doxorubicin—ovarian cancer	0.000863	0.00347	CcSEcCtD
Nitric Oxide—Dyspnoea—Doxorubicin—ovarian cancer	0.000824	0.00331	CcSEcCtD
Nitric Oxide—Dizziness—Epirubicin—ovarian cancer	0.00066	0.00265	CcSEcCtD
Nitric Oxide—Headache—Epirubicin—ovarian cancer	0.000626	0.00251	CcSEcCtD
Nitric Oxide—Dizziness—Doxorubicin—ovarian cancer	0.000611	0.00245	CcSEcCtD
Nitric Oxide—Headache—Doxorubicin—ovarian cancer	0.000579	0.00233	CcSEcCtD
Nitric Oxide—GUCY1B3—Platelet homeostasis—PPP2R1A—ovarian cancer	0.000433	0.0355	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Platelet homeostasis—PPP2R1A—ovarian cancer	0.000433	0.0355	CbGpPWpGaD
Nitric Oxide—ALDH2—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000428	0.0351	CbGpPWpGaD
Nitric Oxide—CYP2B6—Liver X Receptor Pathway—FASN—ovarian cancer	0.000423	0.0347	CbGpPWpGaD
Nitric Oxide—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—ovarian cancer	0.000395	0.0324	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Platelet homeostasis—PPP2R1A—ovarian cancer	0.000386	0.0317	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ATF3—ovarian cancer	0.000344	0.0282	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—NSF—ovarian cancer	0.000312	0.0256	CbGpPWpGaD
Nitric Oxide—ALDH2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000281	0.023	CbGpPWpGaD
Nitric Oxide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.000271	0.0222	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—RAD51C—ovarian cancer	0.000252	0.0206	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—RAD51C—ovarian cancer	0.000252	0.0206	CbGpPWpGaD
Nitric Oxide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	0.000247	0.0202	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—NSF—ovarian cancer	0.000239	0.0196	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—RAD51C—ovarian cancer	0.000224	0.0184	CbGpPWpGaD
Nitric Oxide—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	0.000192	0.0158	CbGpPWpGaD
Nitric Oxide—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.000191	0.0156	CbGpPWpGaD
Nitric Oxide—CYP1A2—Estrogen Receptor Pathway—CYP1B1—ovarian cancer	0.000184	0.0151	CbGpPWpGaD
Nitric Oxide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000172	0.0141	CbGpPWpGaD
Nitric Oxide—ALDH2—Biological oxidations—CYP1B1—ovarian cancer	0.000149	0.0122	CbGpPWpGaD
Nitric Oxide—CYP1A2—Estrogen metabolism—CYP1B1—ovarian cancer	0.000142	0.0116	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—SPARC—ovarian cancer	0.000134	0.011	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—SPARC—ovarian cancer	0.000134	0.011	CbGpPWpGaD
Nitric Oxide—CYP1A2—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000125	0.0103	CbGpPWpGaD
Nitric Oxide—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000125	0.0103	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—SPARC—ovarian cancer	0.00012	0.00981	CbGpPWpGaD
Nitric Oxide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000119	0.00977	CbGpPWpGaD
Nitric Oxide—CYP1A2—Estrogen Receptor Pathway—ESR1—ovarian cancer	0.000116	0.00947	CbGpPWpGaD
Nitric Oxide—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.000109	0.00897	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—SOD1—ovarian cancer	9.76e-05	0.008	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—SOD1—ovarian cancer	9.76e-05	0.008	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PPP2R1A—ovarian cancer	9.71e-05	0.00796	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PPP2R1A—ovarian cancer	9.71e-05	0.00796	CbGpPWpGaD
Nitric Oxide—CYP1A2—Melatonin metabolism and effects—CYP1B1—ovarian cancer	9.68e-05	0.00794	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	9.67e-05	0.00793	CbGpPWpGaD
Nitric Oxide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	9.43e-05	0.00773	CbGpPWpGaD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	9.19e-05	0.00754	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—NME2—ovarian cancer	9.09e-05	0.00745	CbGpPWpGaD
Nitric Oxide—CYP2B6—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	9.07e-05	0.00744	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—SOD1—ovarian cancer	8.7e-05	0.00713	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PPP2R1A—ovarian cancer	8.65e-05	0.00709	CbGpPWpGaD
Nitric Oxide—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	7.94e-05	0.00651	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	7.45e-05	0.00611	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—CAV1—ovarian cancer	7.14e-05	0.00585	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—CAV1—ovarian cancer	7.14e-05	0.00585	CbGpPWpGaD
Nitric Oxide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	7.02e-05	0.00576	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	6.69e-05	0.00549	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	6.69e-05	0.00549	CbGpPWpGaD
Nitric Oxide—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	6.69e-05	0.00549	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PIK3CG—ovarian cancer	6.5e-05	0.00533	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PIK3CG—ovarian cancer	6.5e-05	0.00533	CbGpPWpGaD
Nitric Oxide—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	6.47e-05	0.0053	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—CAV1—ovarian cancer	6.36e-05	0.00521	CbGpPWpGaD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	6.26e-05	0.00513	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL6—ovarian cancer	6.17e-05	0.00506	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYTB—ovarian cancer	5.86e-05	0.0048	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PIK3CG—ovarian cancer	5.79e-05	0.00475	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PIK3CD—ovarian cancer	5.71e-05	0.00468	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PIK3CD—ovarian cancer	5.71e-05	0.00468	CbGpPWpGaD
Nitric Oxide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	5.69e-05	0.00466	CbGpPWpGaD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	5.42e-05	0.00444	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	5.41e-05	0.00444	CbGpPWpGaD
Nitric Oxide—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	5.34e-05	0.00438	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	5.17e-05	0.00424	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PPP1CC—ovarian cancer	5.12e-05	0.0042	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—BRIP1—ovarian cancer	5.12e-05	0.0042	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PIK3CD—ovarian cancer	5.09e-05	0.00417	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PIK3CB—ovarian cancer	4.98e-05	0.00408	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PIK3CB—ovarian cancer	4.98e-05	0.00408	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—IL2—ovarian cancer	4.57e-05	0.00375	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—IL2—ovarian cancer	4.57e-05	0.00375	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PIK3CB—ovarian cancer	4.44e-05	0.00364	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	4.39e-05	0.0036	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.22e-05	0.00346	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	4.2e-05	0.00345	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	4.18e-05	0.00342	CbGpPWpGaD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	4.12e-05	0.00338	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—IL2—ovarian cancer	4.08e-05	0.00334	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—CYP1B1—ovarian cancer	3.96e-05	0.00324	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—CYP1B1—ovarian cancer	3.9e-05	0.0032	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—VEGFA—ovarian cancer	3.89e-05	0.00319	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—VEGFA—ovarian cancer	3.89e-05	0.00319	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—NRAS—ovarian cancer	3.84e-05	0.00315	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—NRAS—ovarian cancer	3.84e-05	0.00315	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—MAPK3—ovarian cancer	3.68e-05	0.00301	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—MAPK3—ovarian cancer	3.68e-05	0.00301	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—MAPK1—ovarian cancer	3.5e-05	0.00287	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—MAPK1—ovarian cancer	3.5e-05	0.00287	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—VEGFA—ovarian cancer	3.46e-05	0.00284	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—YAP1—ovarian cancer	3.43e-05	0.00282	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—NRAS—ovarian cancer	3.42e-05	0.00281	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.39e-05	0.00278	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	3.39e-05	0.00278	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—KRAS—ovarian cancer	3.3e-05	0.00271	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—KRAS—ovarian cancer	3.3e-05	0.00271	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—MAPK3—ovarian cancer	3.28e-05	0.00269	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—MAPK1—ovarian cancer	3.24e-05	0.00265	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—MAPK1—ovarian cancer	3.12e-05	0.00256	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PIK3CA—ovarian cancer	3.04e-05	0.00249	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PIK3CA—ovarian cancer	3.04e-05	0.00249	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—KRAS—ovarian cancer	2.95e-05	0.00241	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—TP53—ovarian cancer	2.94e-05	0.00241	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—TP53—ovarian cancer	2.94e-05	0.00241	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	2.86e-05	0.00234	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	2.86e-05	0.00234	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—HRAS—ovarian cancer	2.81e-05	0.0023	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—HRAS—ovarian cancer	2.81e-05	0.0023	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—FASN—ovarian cancer	2.8e-05	0.00229	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	2.8e-05	0.00229	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—SLC5A5—ovarian cancer	2.75e-05	0.00226	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PIK3CA—ovarian cancer	2.71e-05	0.00222	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—SLC2A1—ovarian cancer	2.66e-05	0.00218	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—TP53—ovarian cancer	2.62e-05	0.00215	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—HRAS—ovarian cancer	2.6e-05	0.00213	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYP1B1—ovarian cancer	2.55e-05	0.00209	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—HRAS—ovarian cancer	2.5e-05	0.00205	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—AKT1—ovarian cancer	2.48e-05	0.00203	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—AKT1—ovarian cancer	2.48e-05	0.00203	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NME2—ovarian cancer	2.41e-05	0.00198	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	2.38e-05	0.00195	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	2.35e-05	0.00192	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	2.33e-05	0.00191	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	2.3e-05	0.00188	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PPP2R1A—ovarian cancer	2.26e-05	0.00185	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—AKT1—ovarian cancer	2.21e-05	0.00181	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	2.19e-05	0.00179	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	2.14e-05	0.00175	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	2.14e-05	0.00175	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	2.14e-05	0.00175	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ABCB1—ovarian cancer	2.1e-05	0.00172	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—TYMS—ovarian cancer	2.06e-05	0.00169	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	2.02e-05	0.00166	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	1.8e-05	0.00147	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	1.8e-05	0.00147	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	1.77e-05	0.00145	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	1.72e-05	0.00141	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CAV1—ovarian cancer	1.66e-05	0.00136	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYTB—ovarian cancer	1.56e-05	0.00127	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PIK3CG—ovarian cancer	1.51e-05	0.00124	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NME2—ovarian cancer	1.42e-05	0.00116	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PPP1CC—ovarian cancer	1.36e-05	0.00111	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—BRIP1—ovarian cancer	1.36e-05	0.00111	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PIK3CD—ovarian cancer	1.33e-05	0.00109	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.21e-05	0.000988	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PIK3CB—ovarian cancer	1.16e-05	0.000951	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NME2—ovarian cancer	1.1e-05	0.000899	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PTEN—ovarian cancer	1e-05	0.000822	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	9.83e-06	0.000806	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYTB—ovarian cancer	9.16e-06	0.000751	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—YAP1—ovarian cancer	9.12e-06	0.000747	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.95e-06	0.000734	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PPP1CC—ovarian cancer	8e-06	0.000656	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—BRIP1—ovarian cancer	8e-06	0.000656	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—FASN—ovarian cancer	7.43e-06	0.000609	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SLC5A5—ovarian cancer	7.31e-06	0.000599	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PIK3CA—ovarian cancer	7.07e-06	0.00058	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYTB—ovarian cancer	7.07e-06	0.000579	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SLC2A1—ovarian cancer	7.06e-06	0.000579	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP1B1—ovarian cancer	6.77e-06	0.000555	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PPP1CC—ovarian cancer	6.18e-06	0.000506	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—BRIP1—ovarian cancer	6.18e-06	0.000506	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	6e-06	0.000492	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.83e-06	0.000478	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—AKT1—ovarian cancer	5.78e-06	0.000473	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ABCB1—ovarian cancer	5.57e-06	0.000457	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—TYMS—ovarian cancer	5.47e-06	0.000449	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—YAP1—ovarian cancer	5.37e-06	0.00044	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.31e-06	0.000436	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.67e-06	0.000383	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CAV1—ovarian cancer	4.41e-06	0.000362	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—FASN—ovarian cancer	4.38e-06	0.000359	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.3e-06	0.000353	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SLC2A1—ovarian cancer	4.16e-06	0.000341	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—YAP1—ovarian cancer	4.14e-06	0.00034	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.07e-06	0.000334	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CG—ovarian cancer	4.02e-06	0.000329	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.99e-06	0.000327	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.53e-06	0.00029	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CD—ovarian cancer	3.53e-06	0.00029	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.52e-06	0.000288	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—FASN—ovarian cancer	3.38e-06	0.000277	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.32e-06	0.000272	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.28e-06	0.000269	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—TYMS—ovarian cancer	3.22e-06	0.000264	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.21e-06	0.000263	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CB—ovarian cancer	3.08e-06	0.000252	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.08e-06	0.000252	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.73e-06	0.000224	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PTEN—ovarian cancer	2.66e-06	0.000218	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CAV1—ovarian cancer	2.6e-06	0.000213	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.53e-06	0.000208	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—TYMS—ovarian cancer	2.49e-06	0.000204	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.48e-06	0.000203	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.37e-06	0.000194	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.08e-06	0.000171	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CAV1—ovarian cancer	2e-06	0.000164	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.88e-06	0.000154	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.83e-06	0.00015	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.81e-06	0.000149	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.61e-06	0.000132	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PTEN—ovarian cancer	1.57e-06	0.000128	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—AKT1—ovarian cancer	1.53e-06	0.000126	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.4e-06	0.000115	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PTEN—ovarian cancer	1.21e-06	9.91e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.11e-06	9.06e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—AKT1—ovarian cancer	9.03e-07	7.4e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.53e-07	6.99e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—AKT1—ovarian cancer	6.97e-07	5.71e-05	CbGpPWpGaD
